Press "Enter" to skip to content

World Leader in Hospital Ultraviolet Disinfection Technology Petitions FDA for Authorization of LightStrike+ Technology

Xenex news release in BusinessWire states it has filed an FDA petition to allow marketing its UV disinfection technology called LightStrike+. SAN ANTONIO–(BUSINESS WIRE)–Xenex Disinfection Services, the world leader in UV disinfection technology for healthcare facilities, today announced it has filed a De Novo petition with the U.S. Food and Drug Administration (“FDA”) for medical device market authorization of its LightStrike+ ultraviolet (UV) room disinfection technology. The company’s patented device uses a xenon lamp to create broad spectrum UV light intended to quickly destroy pathogens on surfaces in healthcare facilities. Xenex’s LightStrike technology is currently being sold pursuant to an FDA enforcement policy…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.